MEDI-DIA s.r.o.

Sabinov, Presov 083 01

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities — Running, not enrolling
• A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin — Completed
• A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus — Completed